Skip to main content
Caplight Logo









Prothea Technologies

Prothea Technologies

Private
EdinburghHealthcare & Life Scienceshttps://prothea.tech/

Last Round

Series A

Apr 9, 2024

Total Funding Raised

$13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Prothea Technologies is a medical technology company that is developing an integrated diagnostic and treatment platform for lung cancer to enable biopsy and treatment in a single hospital visit.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical devicelung cancer diagnosismedical imagingfibreoptic microendoscopemedtechAI-powered diagnosticslaser ablationbronchoscopyclinical decision supportbiopsydigital pathologyinterventional pulmonologyimage processingsurgical robotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prothea Technologies Comparables

Compare Prothea Technologies with similar companies based on industry and business-model similarity.

Prothea Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LEADOPTIK
82%
Prana Surgical
78%
Body Vision Medical
78%

Prothea Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2024

Key People

Founding team and executive leadership

Kev Dhaliwal

Co founder , Chief Scientific Officer Chief Medical Officer

Founding Team

Jim Stone

Chief Technology Officer

Executive Team

Prothea Technologies Investors

Notable investors and investment history

Prothea Technologies investors
InvestorRounds
KorysSeries A
Old College CapitalSeries A
NRW.BankSeries A
Earlybird Venture CapitalSeries A
Mérieux Equity PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 17, 2026

    Grew 22% QoQ, from 18 to 22 employees.

Prothea Technologies Filings

Explore SEC and related filing metadata, where available.

Prothea Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prothea Technologies's valuation, stock price, and market status.

Is Prothea Technologies a public or private company?

Prothea Technologies is a private company.

What is the current stock price of Prothea Technologies?

Prothea Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is Prothea Technologies worth (valuation)?

Valuation information for Prothea Technologies is not publicly available.

Can I buy Prothea Technologies stock?

Prothea Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prothea Technologies's last funding round?

Prothea Technologies's most recent funding round was Series A on April 9, 2024.

Who are the main investors in Prothea Technologies?

Key investors in Prothea Technologies include Earlybird Venture Capital, Mérieux Equity Partners.

Will Prothea Technologies IPO soon?

No public IPO plans have been announced for Prothea Technologies.

How can I track Prothea Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prothea Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEdinburgh
Employee Range22
Year Founded2021
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?